國旅聯合(600358.SH):控股股東完成增資擴股 其註冊資本增至13億元
格隆匯4月3日丨國旅聯合(600358.SH)公佈,2020年4月3日,公司接到控股股東江西省旅遊集團股份有限公司(“江旅集團”)發來的《關於江西省旅遊集團股份有限公司完成增資擴股的函》。函稱,江旅集團已於近日完成增資擴股的工商變更登記,江旅集團註冊資本由10億元變更為13億元。江旅集團此次增資前後的股權結構如下:

江旅集團此次增資擴股不會導致公司的控股股東和實際控制人發生變化。目前,江旅集團持有公司9880.3萬股股票,佔公司總股本的19.57%,為公司的控股股東,江西省國有資產監督管理委員會為公司的實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.